Clinical Research Directory
Browse clinical research sites, groups, and studies.
iCAGES-guided Precision Therapy for Cancers in Contrast to Standard Care or IHC-guided Theray
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Summary
This study prospectively evaluates whether the use of iCAGES (integrated CAncer GEnome Score) tool in guiding the treatment of advanced cancers is superior to current standard care or IHC-guided therapy in progress free survival (PFS),overall survival (OS),and improvement of life quality.
Official title: Multicentre Perspective Non-interventional Study of Survival Benefits of iCAGES-guided Therapy in Contrast to Standard Therapy or IHC-guided Therapy for Advanced Cancers
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
OBSERVATIONAL
Enrollment
250
Start Date
2017-07-01
Completion Date
2039-07-01
Last Updated
2024-06-25
Healthy Volunteers
No
Interventions
inhibitors, ADC drugs such as tarceva, capmatinib, padcev et al for A/C group.
Choose appropriate targeted drugs according to NGS/IHC results.
Locations (1)
The Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China